![]() |
|
|
Vol. 286, Issue 2, 896-902, August 1998
-thio)-triphosphate Binding in Rat Brain
Membranes1
Department of Peptide Pharmacology (E.A., S.O., I.B., H.B.),
Research Institute of Molecular Pharmacology, Berlin, Germany and
Cardiology Research Centre (N.N.S.), Academy of Medical Sciences,
Moscow, Russia
G protein activation by the agonist-occupied nociceptin- (orphanin FQ-)
receptor in rat cerebral cortex was studied by characterizing the
nociceptin-stimulated binding of the radiolabeled guanylyl triphosphate
(GTP) analog 35S-guanylyl-5'-O-(
-thio)-triphosphate
(GTP
S). Using 3H-Tyr14- and
125I-Tyr14-nociceptin in saturation and
displacement receptor binding studies, a single high-affinity
(Kd 21.6-116.7 pM) and high-capacity binding site for nociceptin (orphanin FQ) in membranes and sections of
rat cerebral cortex was identified. Stable GTP analogs and NaCl lowered
the affinity only moderately by 2- to 3-fold, but under these
conditions nociceptin stimulated the binding of
35S-GTP
S to G proteins in the membranes with a
potency about 100-fold lower (EC50 9.11 nM). It was
estimated that this stimulation was due to a 29-fold increase in the
affinity from Kd 45.8 to 1.57 nM of
only about 6.5% of the basal binding sites for GTP
S, and that at
least 10 G protein binding sites could be stimulated by one receptor
site. The link of this nociceptin-stimulated binding of GTP to the
nociceptin receptor was further evidenced by the specificity of
stimulation, as seen with nociceptin, nociceptin(1-13), D-Ala7-nociceptin and
nociceptin(1-9), which paralleled that of their receptor affinities.
Furthermore, the distribution in rat brain regions of the binding of
35S-GTP
S stimulated by nociceptin differed from that
stimulated by the mu opioid agonist
[D-Ala2, N-Me-Phe4,
Gly5-ol)]-enkephalin. Especially, no stimulation by
nociceptin was observed in caudate putamen, where also the absence of
ORL1 receptors had been reported. The putative coupling of the
high-affinity nociceptin receptor to the low-potency stimulation of
GTP
S binding in rat cerebral cortex might be explained by the switch
of a low part of occupied nociceptin binding sites to a very
low-affinity state being stabilized at high peptide concentrations and
catalytically stimulating the GTP binding.
This article has been cited by other articles:
![]() |
J. S. Mogil and G. W. Pasternak The Molecular and Behavioral Pharmacology of the Orphanin FQ/Nociceptin Peptide and Receptor Family Pharmacol. Rev., September 1, 2001; 53(3): 381 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Berger, G. Calo', E. Albrecht, R. Guerrini, and M. Bienert [Nphe1]NC(1-13)NH2 Selectively Antagonizes Nociceptin/Orphanin FQ-Stimulated G-Protein Activation in Rat Brain J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 428 - 433. [Abstract] [Full Text] |
||||
![]() |
K. Wenzel-Seifert, J. M. Arthur, H.-Y. Liu, and R. Seifert Quantitative Analysis of Formyl Peptide Receptor Coupling to Gialpha 1, Gialpha 2, and Gialpha 3 J. Biol. Chem., November 19, 1999; 274(47): 33259 - 33266. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Seifert, U. Gether, K. Wenzel-Seifert, and B. K. Kobilka Effects of Guanine, Inosine, and Xanthine Nucleotides on beta 2-Adrenergic Receptor/Gs Interactions: Evidence for Multiple Receptor Conformations Mol. Pharmacol., August 1, 1999; 56(2): 348 - 358. [Abstract] [Full Text] |
||||